Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2026-06-02 19:00:04 ET · period of report 2026-05-29 · accession 0001193125-26-254038 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-06-02 19:00 | 2026-05-29+ | AXSM | Coleman Mark | Dir | S - Sale | $229.20 | -17.5K | 29.6K | -37% | -$4.02M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-29 | S | D | 6,000 | $233.46 | 41,140 | D | — | — | (F1) Represents the sale of underlying shares of previously exercised stock options. (F2) Such transaction was pursuant to a pre-approved 10b5-1 plan. (F3) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $231.50 and $235.23. |
| 2 | Common | Common Stock | 2026-06-01 | S | D | 6,000 | $230.30 | 35,140 | D | — | — | (F1) Represents the sale of underlying shares of previously exercised stock options. (F2) Such transaction was pursuant to a pre-approved 10b5-1 plan. (F4) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $229.56 and $232.14. |
| 3 | Common | Common Stock | 2026-06-02 | S | D | 5,537 | $223.39 | 29,603 | D | — | — | (F1) Represents the sale of underlying shares of previously exercised stock options. (F2) Such transaction was pursuant to a pre-approved 10b5-1 plan. (F5) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $221.82 and $225.21. |